• IP addresses are NOT logged in this forum so there's no point asking. Please note that this forum is full of homophobes, racists, lunatics, schizophrenics & absolute nut jobs with a smattering of geniuses, Chinese chauvinists, Moderate Muslims and last but not least a couple of "know-it-alls" constantly sprouting their dubious wisdom. If you believe that content generated by unsavory characters might cause you offense PLEASE LEAVE NOW! Sammyboy Admin and Staff are not responsible for your hurt feelings should you choose to read any of the content here.

    The OTHER forum is HERE so please stop asking.

HIV with newly found power of mutation - Gays must all DIE ASAP!

kangaroo

Alfrescian
Loyal
https://biotechin.asia/2016/04/11/hiv-can-adapt-to-crispr-gene-editing-in-two-weeks/


HIV can adapt to CRISPR gene editing; in two weeks!

HIV took just 2 weeks to overcome our best attempt to edit it out of our cells

A recent development brought much excitement in the scientific community. Researchers from the Francis Crick Institute in UK had announced that they had successfully removed HIV from human immune cells using a revolutionary gene editing technology called CRISPR/Cas-9 (CRISPR in short). CRISPR is a technology that works like a pair of molecular scissors to cut and paste DNA.

Worryingly though, another study has reported that HIV can evolve to survive CRISPR attacks in just two weeks. In fact, the attack by itself might be introducing mutations that make the virus stronger, researchers say.
hiv 1

hiv-1.jpg

Vanquishing HIV just got that little bit harder (http://bit.Iy/1SYw1Dy)

HIV is a deadly virus that infects our immune cells. Post infection, it inserts its genome into our cells’ DNA, and then hijacks the cell to churn out more copies of itself. While antiretroviral drugs can successfully keep active HIV infections under control and extend patients’ lifespans, no one has been able to get dormant HIV DNA out of our cells, so it’s always lying in wait for the day the drugs stop. However, with the advent of CRISPR system in 2012, there was a lot of hope that it could be used to attack this dormant HIV genome and eliminate the virus from our system.

Some recent studies, like this study from McGill University, Canada, have shown extremely promising data to use CRISPR to cut up viral DNA. Thus, the virus should be effectively disabled. Unfortunately, the same group also reported that within 2 weeks, the cells started pumping out more copies of the virus. Strikingly, the virus was now stronger and resistant to CRISPR. However, the researchers involved say that the discovery is a minor setback that does not preclude the idea altogether.

Chen Liang, the lead author of the study, and his team had thought that by cutting HIV up into little pieces using CRISPR, the cell would try to patch it up (as it automatically does) and introduce ‘scar tissue’ into the sequence that would stop the virus from replicating and effectively disable it. Although, it was successful initially, some of the viruses survived and the alterations only made the virus stronger such that CRISPR was not able to attack it again.

“On the one hand, CRISPR inhibits HIV, but on the other, it helps the virus to escape and survive,” says Liang. He further adds, “The surprise is that the resistance mutations are not the products of error-prone viral DNA copying, but rather are created by the cell’s own repair machinery.”

Come to think of it, it’s not overtly surprising though. HIV has shown the ability to resist all kinds of antiviral drugs in the recent past. It does so because it is equipped with a highly error prone enzyme that copies its genome. Most mistakes stop the virus working, but occasionally a mutation is beneficial for HIV, allowing it to evade attack. But what is surprising in this instance is just how fast HIV bounced back, and the fact that our own cells seemed to have given the virus these handy mutations.

Liang still stays optimistic. “The bright side is that when you know what the problem is, you can come up with the means to overcome it,” he quips. “Just as HIV is able to escape all antiretroviral drugs, understanding how HIV escapes only helps you discover better drugs or treatments.” One possibility is to “carpet-bomb” HIV with CRISPR at many sites within its DNA instead of just the one targeted in the experiment. This, says, Liang, would make it much more difficult for the virus to evolve resistance. “Fortunately, the field is advancing very fast … I think CRISPR is easy and specific enough to use. I think we’ll see better tools [to fight HIV] soon.”

This setback might be a blessing in disguise indeed. We now know the flaws of the CRISPR/Cas-9 system, so we’ll strive to get better at using it to stop HIV for good.
 

tonychat

Alfrescian (InfP)
Generous Asset
Scientists are stupid, they dun have conscious understanding of things surrounding them.. I thought scientists should be the one who knows about nature more than the common people, it's their job.
 

Ralders

Alfrescian
Loyal
Scientists are stupid, they dun have conscious understanding of things surrounding them.. I thought scientists should be the one who knows about nature more than the common people, it's their job.

Now u scare.... fucktard gay
 

swine_flu_H1H1

Alfrescian
Loyal
w-science-graphic.jpg


Man do not even have such ability to acquire resistence to ailments. But bacterials and virus are so powerful.


http://www.livemint.com/Politics/Vh...w-bacteria-develop-antibiotic-resistance.html


How bacteria develop antibiotic resistance
Bacteria that can resist antibiotics have a greater chance of survival than those susceptible to the drugs

28



Subscribe to our newsletter.
Jyotsna Singh

Antibiotic resistance is a consequence of evolution via natural selection. Photo: iStockphoto
New Delhi: Antibiotic resistance occurs when a drug loses its ability to effectively control or kill bacterial growth. The bacteria multiply even in the presence of therapeutic levels of an antibiotic. A patient who has turned antibiotic-resistant cannot be treated for diseases requiring the drugs.

Antibiotic resistance is a big challenge in India. In a survey, the National Centre for Disease Control (NCDC) found last year that 20% of patients were resistant to the most advanced antibiotics class, carbapenems. The survey was conducted in seven tertiary care government hospitals in various cities of India.

“Carbapenems are the last-resort antibiotics to treat serious and potentially lethal infections. Patients who have compromised immunity like those with kidney disorders, cancers and urinary tract infections, face troubles in recovering from even simple infections. Resistance toward carbapenem is being found even among healthy individuals,” said Sunil Gupta, joint director, microbiology division, NCDC, who is overseeing the surveillance programme.

Antibiotic resistance is a consequence of evolution via natural selection. Bacteria that can resist antibiotics have a greater chance of survival than those that are susceptible to the drugs. These susceptible bacteria are killed by antibiotics, resulting in selective pressure for the survival of resistant strains of bacteria.

“Bacteria develop resistance through mutations and by acquiring resistance through other bacteria,” said Chand Wattal, who heads the department of clinical microbiology at Sir Ganga Ram Hospital, New Delhi.

Some bacteria are naturally resistant to certain types of antibiotics due to their structure. Other bacteria become resistant in two ways: through genetic mutation or by acquiring resistance from another bacterium.

Mutations are rare spontaneous changes of the bacteria’s genetic material, which are thought to take place in about one in one million to one in ten million cells. There are many ways through which mutations help bacteria develop resistance. Some mutations enable the bacteria to produce potent chemicals, called enzymes, that make antibiotics inactive.

Mutations can also eliminate the target in the cell of the bacteria that the antibiotic attacks.

Other mutations close up the entry points through which antibiotics enter the cell.

Other types of mutations manufacture pumping mechanisms that export the antibiotics back outside before they reach the target.


Click here for enlarge
Bacteria can also acquire antibiotic resistance from other bacteria through several routes. One is “conjugation”, a simple mating process in which bacteria can transfer genetic material, including genes encoding resistance to antibiotics, from one bacterium to another.

Such encodings are found on DNA molecules called plasmids and a small part of the DNA called transposons.

Viruses are another mechanism for passing on antibiotic resistance. The resistance traits of one bacterium are packaged into the head of the virus, which injects it into other bacteria it attacks.

Bacteria also have the ability to acquire free DNAs with encoded resistance from the environment. The bacteria then pass on such acquired traits to their offspring, which will be a fully resistant generation.

Through the two actions—increasing share of resistant bacteria in the existing population and creating a new generation that’s fully resistant—the bacteria spread resistance against antibiotics.

Overuse of broad-spectrum antibiotics, such as second- and third-generation cephalosporins, accelerates the development of resistance to the antibiotic methicillin, related to penicillin.

Apart from this, many other factors contribute towards resistance, including incorrect diagnosis. Other factors contributing towards resistance include incorrect diagnosis.

Use of antibiotics as food additives for growth promotion in poultry is another issue. Antibiotics fed to animals meant for human consumption enter the food chain and lead to resistance.

The only solution is to keep developing new antibiotics for human use.

“However, after carbapenems, no new antibiotics have been developed. This is a scary situation,” said Gupta.

A new class of antibiotics is under development. But it will take at least seven to eight years before this hits the market, said Radha Rangarajan, founder and CEO, Vitas Pharma Pvt. Ltd.
 
Top